GITR contributes to the systemic adjuvanticity of the Escherichia coli heat-labile enterotoxin

European Journal of Immunology

Volumn 40, Issue 3, 2010, Pages 754-763

  Tamayo, Esther ^a   Postigo, Jorge ^a   González, Jovanna ^a   Fernández Rey, Maigualida ^a   Iglesias, Marcos ^a   Santiuste, Inés ^a   Riccardi, Carlo ^b   Rappuoli, Rino ^c   Del Giudice, Giuseppe ^c   Merino, Ramón ^a   Merino, Jesús ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b UNIVERSITY OF PERUGIA   (Italy)

^c NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Costimulation; T cells; Vaccination

Indexed keywords

ADJUVANT; ALUMINUM HYDROXIDE; CHOLERA TOXIN; ESCHERICHIA COLI ENTEROTOXIN; FREUND ADJUVANT; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NEOMYCIN; OMEPRAZOLE; OVALBUMIN;

ADRENALECTOMY; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BAGG ALBINO MOUSE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; FOOT PAD; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; INGUINAL LYMPH NODE; INJECTION SITE; INTESTINE MUCOSA; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TOXIN ANALYSIS; VACCINATION; WILD TYPE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; FLOW CYTOMETRY; IMMUNITY, MUCOSAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77749285672     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939865     Document Type: Article

References (32)

1. Freytag, L. C. and Clements, J. D., Mucosal adjuvants. Vaccine 2005. 23: 1804-1813.
2. Rappuoli, R., Pizza, M., Douce, G. and Dougan, G., Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Immunol. Today 1999. 20: 493-500.
3. Tamayo, E., Merino, R., Gonzá lez-Rojas, J., Marquina, R., Santiuste, I., Amado, J. A., Rappuoli, R. et al., The Escherichia coli heat-labile enterotoxin induces apoptosis of immature lymphocytes in vivo via a glucocorticoid-dependent pathway. Eur. J. Immunol. 2005. 35: 3505-3515.
4. Douce, G., Giannelli, V., Pizza, M., Lewis, D., Everest, P., Rappuoli, R. and Dougan, G., Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants. Infect. Immun. 1999. 67: 4400-4406.
5. Giuliani, M. M., Del Giudice, G., Giannelli, V., Dougan, G., Douce, G., Rappuoli, R. and Pizza, M., Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity. J. Exp. Med. 1998. 187: 1123-1132.
6. Peppoloni, S., Ruggiero, P., Contorni,M.,Morandi,M., Pizza,M., Rappuoli, R., Podda, A. and Del Giudice, G., Mutants of Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines. Expert Rev. Vaccines 2003. 2: 285-293.
7. van Ginkel, F. W., Jackson, R. J., Yuki, Y. and McGhee, J. R., The mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J. Immunol. 2000. 165: 4778-4782.
8. Mutsch, M., Zhou,W., Rhodes, P., Bopp, M., Chen, R. T., Linder, T., Spyr, C. and Steffen, R., Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N. Engl. J. Med. 2004. 350: 896-903.
9. Lewis, D. J. M., Huo, Z., Barnett, S., Kromann, I., Giemza, R., Galiza, E., Woodrow, M. et al., Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin. PLoS ONE 2009. 4: e6999.
10. Simmons, C. P., Mastroeni, P., Fowler, R., Ghaem-maghami, M., Lycke, N., Pizza, M., Rappuoli, R. and Dougan, G., MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants. J. Immunol. 1999. 163: 6502-6510.
11. Neidleman, J. A., Vajdy, M., Ugozzoli, M., Ott, G. and O'Hagan, D., Genetically detoxified mutants of heat-labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55. Immunology 2000, 101: 154-160.
12. Grdic, D., Ekman, L., Schön, K., Lindgren, K., Mattsson, J., Magnusson, K. E., Ricciardi-Castagnoli, P. and Lycke, N., Splenic marginal zone dendritic cells mediate the cholera toxin adjuvant effect: dependence on the ADP-ribosyltransferase activity of the holotoxin. J. Immunol. 2005. 175: 5192-5202.
13. Gagliardi, M. C., Sallusto, F., Marinaro, M., Langenkamp, A., Lanzavecchia, A., and De Magistris, M. T., Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. Eur. J. Immunol. 2000. 30: 2394-2403.
14. Anjuère, F., Luci, C., Lebens, M., Rousseau, D., Hervouet, C., Milon, G., Holmgren, J. et al., In vivo adjuvant-induced mobilization and maturation of gut dendritic cells after oral administration of cholera toxin. J. Immunol. 2004. 173: 5103-5111.
15. Yamamoto, M., Kiyono, H., Yamamoto, S., Batanero, E., Kweon, M. N., Otake, S., Azuma, M. et al., Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant. J. Immunol. 1999. 162: 7015-7021.
16. Tamayo, E., Postigo, J., Del Giudice, G., Rappuoli, R., Benito, A., Yagita, H., Merino, R. and Merino, J., Involvement of the intrinsic and extrinsic cell death pathways in the induction of apoptosis of mature lymphocytes by the Escherichia coli heat-labile enterotoxin. Eur. J. Immunol. 2009. 39: 439-446.
17. Ronchetti, S., Zollo, O., Bruscoli, S., Agostini, M., Bianchini, R., Nocentini, G., Ayroldi, E. and Riccardi, C., GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur. J. Immunol. 2004. 34: 613-622.
18. Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y. and Sakaguchi, S., Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 2002. 3: 135-142.
19. Lee, H. S., Shin, H. H., Kwon, B. S. and Choi, H. S., Soluble glucocorticoidinduced tumor necrosis factor receptor (sGITR) increased MMP-9 activity in murine macrophage. J. Cell Biochem. 2003. 88:1048-1056.
20. Weigle,W. O., Scheuer,W. V., Hobbs, M. V., Morgan, E. L. and Parks, D. E., Modulation of the induction and circumvention of immunological tolerance to human gamma-globulin by interleukin 1. J. Immunol. 1987. 138: 2069-2074.
21. Cox, E., Verdonck, F., Vanrompay, D. and Goddeeris, B., Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa. Vet. Res. 2006. 37: 511-539.
22. Nocentini, G., Giunchi, L., Ronchetti, S., Krausz, L. T., Bartoli, A., Moraca, R., Migliorati, G. and Riccardi, C., A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc. Natl. Acad. Sci. USA 1997. 94: 6216-6221.
23. Agostini, M., Cenci, E., Pericolini, E., Nocentini, G., Bistoni, G., Vecchiarelli, A. and Riccardi, C., The glucocorticoid-induced tumor necrosis factor receptor-related gene modulates the response to Candida albicans infection. Infect. Immun. 2005. 73: 7502-7508.
24. Norihisa, Y., McVicar, D. W., Ghosh, P., Houghton, A. N., Longo, D. L., Creekmore, S. P., Blake, T. et al., Increased proliferation, cytotoxicity, and gene expression after stimulation of human peripheral blood lymphocytes through a surface ganglioside (GD3). J. Immunol. 1994. 152: 485-495.
25. Viola, A., Schroeder, S., Sakakibara, Y. and Lanzavecchia, A., T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 1999. 283: 680-682.
26. Richards, C. M., Aman, A. T., Hirst, T. R., Hill, T. J. and Williams, N. A., Protective mucosal immunity to ocular herpes simplex virus type infection in mice by using Escherichia coli heat-labile enterotoxin subunit as an adjuvant. J. Virol. 2001. 75: 1664-1671.
27. Tamura, S., Funato, H., Nagamine, T., Aizawa, C. and Kurata, T., Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB. Vaccine 1989. 7: 503-505.
28. Holmgren, J. and Czerkinsky, C., Mucosal immunity and vaccines. Nat. Med. 2005. 11: S45-53.
29. Cong, Y., Weaver, C. T. and Elson, C. O., The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression. J. Immunol. 1997. 159: 5301-5308.
30. Newton, K., Harris, A. W., Bath, M. L., Smith, K. G. and Strasser, A., A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 1998. 17: 706-718.
31. Ronchetti, S., Nocentini, G., Riccardi, C. and Pandolfi, P. P., Role of GITR in activation response of T lymphocytes. Blood 2002. 100: 350-352.
32. Shen, H., Boyer, M. and Cheng, T., Flow cytometry-based cell cycle measurement of mouse hematopoietic stem and progenitor cells. Methods Mol. Biol. 2008. 430: 77-86.